Completed
BAY1830839: First in Man, Single Dose Escalation, Safety & Tolerability and Pharmacokinetics
NCT03540615
- Conditions
- Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +6 more
- Locations
-
- CRS Clinical Research Services Berlin GmbH Berlin, Germany